Low-dose taurine upregulates taurine transporter expression in acute myocardial ischemia.

Taurine exerts a protective effect on cardiomyocytes. The aim of this study was to determine whether the protective effect of taurine is associated with the upregulation of taurine transporter (TAUT) expression in acute myocardial ischemia (AMI). To this end, we investigated TAUT expression in cultured cardiomyocytes exposed to hypoxia as well as in rats with AMI treated with or not with taurine. The morphology of cardiac tissues, the apoptosis of cardiomyocytes and cardiac function were examined. In addition, the taurine content and the expression of TAUT were measured. Our data demonstrated that taurine reversed the apoptosis induced by hypoxia and AMI, thereby, effectively protecting the myocardium. Taurine content and TAUT expression levels were significantly decreased when cardiomyocytes and cardiac tissues were subjected to hypoxic or ischemic stress, while the expression of cysteine sulfinate decarboxylase was unchanged. Moreover, treatment with taurine (100 mg/kg/day) significantly upregulated TAUT expression and elevated the taurine content in ischemic myocardial tissues. In vitro, the low-dose (40 mM) but not the high-dose (120 mM) administration of taurine significantly induced TAUT expression and elevated the intracellular taurine content in hypoxic cardiomyocytes. In conclusion, our data demonstrate that taurine exerts a protective effect on the ischemic myocardium. Low-dose but not high-dose taurine treatment upregulated TAUT expression and increased the intracellular taurine content in cardiomyocytes subjected to hypoxia as well as in AMI tissues.

[1]  U. Demirkılıç,et al.  Is there any cardioprotective role of Taurine during cold ischemic period following global myocardial ischemia? , 2011, Journal of cardiothoracic surgery.

[2]  Ka Chen,et al.  Effects of Taurine on Glial Cells Apoptosis and Taurine Transporter Expression in Retina Under Diabetic Conditions , 2010, Neurochemical Research.

[3]  J. Das,et al.  Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa B, p38 and JNK MAPK pathway. , 2009, Toxicology and applied pharmacology.

[4]  Dariush Mozaffarian,et al.  Fish intake, contaminants, and human health: evaluating the risks and the benefits. , 2006, JAMA.

[5]  M. Komeda,et al.  Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation , 2005, Heart and Vessels.

[6]  A. Nehlig,et al.  Metabolism is Normal in Astrocytes in Chronically Epileptic Rats: A 13C NMR Study of Neuronal—Glial Interactions in a Model of Temporal Lobe Epilepsy , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  Y. Fujio,et al.  Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome. , 2004, American journal of physiology. Cell physiology.

[8]  N. Khaper,et al.  Taurine Supplementation Reduces Oxidative Stress and Improves Cardiovascular Function in an Iron-Overload Murine Model , 2004, Circulation.

[9]  Y. Fujio,et al.  Taurine prevents the ischemia-induced apoptosis in cultured neonatal rat cardiomyocytes through Akt/caspase-9 pathway. , 2004, Biochemical and biophysical research communications.

[10]  Chao-shu Tang,et al.  EFFECTS OF TAURINE AND HOMOCYSTEINE ON CALCIUM HOMEOSTASIS AND HYDROGEN PEROXIDE AND SUPEROXIDE ANIONS IN RAT MYOCARDIAL MITOCHONDRIA , 2004, Clinical and experimental pharmacology & physiology.

[11]  M. Shimizu,et al.  Functional characterization and regulation of the taurine transporter and cysteine dioxygenase in human hepatoblastoma HepG2 cells. , 2003, The Biochemical journal.

[12]  Chao-shu Tang,et al.  Inhibition of taurine transport by high concentration of glucose in cultured rat cardiomyocytes. , 2003, Metabolism: clinical and experimental.

[13]  J. Azuma,et al.  Taurine Renders the Cell Resistant to Ischemia-induced Injury in Cultured Neonatal Rat Cardiomyocytes , 2003, Journal of cardiovascular pharmacology.

[14]  Chao-shu Tang,et al.  Dysfunction of myocardial and vascular taurine transport in spontaneously hypertensive rats. , 2002, Sheng li xue bao : [Acta physiologica Sinica].

[15]  O. Levillain,et al.  Gene expression of the taurine transporter and taurine biosynthetic enzymes in rat kidney after antidiuresis and salt loading , 2001, Pflügers Archiv.

[16]  O. Levillain,et al.  Regional Expression and Histological Localization of Cysteine Sulfinate Decarboxylase mRNA in the Rat Kidney1 , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[17]  M. Bitoun,et al.  Gene expression of the transporters and biosynthetic enzymes of the osmolytes in astrocyte primary cultures exposed to hyperosmotic conditions , 2000, Glia.

[18]  N. Sperelakis,et al.  Review of some actions of taurine on ion channels of cardiac muscle cells and others. , 1998, General pharmacology.

[19]  J. Olson,et al.  Taurine synthesis and cysteine metabolism in cultured rat astrocytes: effects of hyperosmotic exposure. , 1998, American journal of physiology. Cell physiology.

[20]  R. Chesney,et al.  Adaptive regulation of MDCK cell taurine transporter (pNCT) mRNA: transcription of pNCT gene is regulated by external taurine concentration. , 1997, Biochimica et biophysica acta.

[21]  R. Blakely,et al.  Functional characterization and chromosomal localization of a cloned taurine transporter from human placenta. , 1994, The Biochemical journal.

[22]  J. Azuma,et al.  Beneficial effect of taurine in rabbits with chronic congestive heart failure. , 1986, American heart journal.

[23]  J. Azuma,et al.  Therapeutic effect of taurine in congestive heart failure: A double‐blind crossover trial , 1985, Clinical cardiology.

[24]  T. Peng,et al.  Taurine prevents cardiomyocyte death by inhibiting NADPH oxidase-mediated calpain activation. , 2009, Free radical biology & medicine.

[25]  M. Tappaz.  Taurine Biosynthetic Enzymes and Taurine Transporter: Molecular Identification and Regulations , 2004, Neurochemical Research.

[26]  M. Shimizu,et al.  Functional characterization and regulation of the taurine transporter and cysteine dioxygenase in human hepatoblastoma HepG 2 cells , 2003 .

[27]  J. Azuma,et al.  Role of osmoregulation in the actions of taurine , 2000, Amino Acids.

[28]  R. Korpela,et al.  Role of arginine, taurine and homocysteine in cardiovascular diseases. , 1999, Annals of medicine.

[29]  R J Huxtable,et al.  Physiological actions of taurine. , 1992, Physiological reviews.

[30]  H. Iwata,et al.  Taurine and the Heart , 1989, Developments in Cardiovascular Medicine.

[31]  J. Azuma,et al.  Therapy of congestive heart failure with orally administered taurine. , 1983, Clinical therapeutics.